Pharmacokinetics and pharmacodynamics of mibavademab (a leptin receptor agonist): Results from a first-in-human phase I study.

Clin Transl Sci · 2024 · PMC11003274 · PMID 38591811

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The PK data showed a trend towards increasing concentrations of total mibavademab with increasing levels of baseline leptin (Figure 3a ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.